Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Gastric Cancer

  Free Subscription


1 Am J Gastroenterol
4 Anticancer Res
1 BMC Gastroenterol
1 Br J Cancer
1 Dig Dis Sci
4 Eur J Surg Oncol
1 Gastroenterology
1 J Gastroenterol Hepatol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Gastroenterol

  1. TU H, Sun L, Dong X, Gong Y, et al
    A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
    Am J Gastroenterol. 2017 Mar 21. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available

    Anticancer Res

  2. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
    Anticancer Res. 2017;37:1343-1347.
    PubMed     Text format     Abstract available

  3. MITA K, Ito H, Ota E, Takahashi K, et al
    Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection.
    Anticancer Res. 2017;37:1329-1333.
    PubMed     Text format     Abstract available

  4. AHN SY, Kim J, Kim MA, Choi J, et al
    Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
    Anticancer Res. 2017;37:1127-1138.
    PubMed     Text format     Abstract available

  5. DAI X, Liu D, Liu M, Zhang X, et al
    Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
    Anticancer Res. 2017;37:979-986.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  6. ZHU Y, Sun Y, Hu S, Jiang Y, et al
    Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    BMC Gastroenterol. 2017;17:41.
    PubMed     Text format     Abstract available

    Br J Cancer

  7. BAI T, Yokobori T, Altan B, Ide M, et al
    High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Br J Cancer. 2017 Mar 23. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

    Dig Dis Sci

    Long Non-coding RNAs in Gastric Cancer: A True Relationship or miR Chance?
    Dig Dis Sci. 2017 Mar 17. doi: 10.1007/s10620-017-4537.
    PubMed     Text format    

    Eur J Surg Oncol

    Is there role for laparoscopic gastrectomy for advanced gastric cancer.
    Eur J Surg Oncol. 2017 Mar 8. pii: S0748-7983(17)30363.
    PubMed     Text format    

  10. CHOI YY, Cheong JH
    Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Eur J Surg Oncol. 2017 Mar 1. pii: S0748-7983(17)30360.
    PubMed     Text format     Abstract available

  11. XIE JW, Sun YQ, Feng CY, Zheng CH, et al
    Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
    Eur J Surg Oncol. 2016;42:1464-70.
    PubMed     Text format     Abstract available

  12. MOSQUERA C, Koutlas NJ, Fitzgerald TL
    Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Eur J Surg Oncol. 2016;42:1471-7.
    PubMed     Text format     Abstract available


    The AGA/Funderburg Award in Gastric Cancer: Twenty-five years of advances in gastric cancer research.
    Gastroenterology. 2017 Mar 18. pii: S0016-5085(17)30293.
    PubMed     Text format    

    J Gastroenterol Hepatol

  14. FURUKAWA K, Miyahara R, Funasaka K, Asai H, et al
    Gastrointestinal: Gastric mixed adenoneuroendocrine carcinoma.
    J Gastroenterol Hepatol. 2016;31:1236.
    PubMed     Text format    

    PLoS One

  15. VALAEE S, Yaghoobi MM, Shamsara M
    Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.
    PLoS One. 2017;12:e0174486.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.